Drug Profile
Research programme: histamine H3 receptor antagonists - GlaxoSmithKline
Alternative Names: GSK 207040; GSK 334429Latest Information Update: 19 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis; Dementia; Neuropathic pain; Pain
Most Recent Events
- 28 Feb 2011 No development reported - Preclinical for Allergic rhinitis in United Kingdom (unspecified route)
- 28 Feb 2011 No development reported - Preclinical for Dementia in United Kingdom (PO)
- 28 Feb 2011 No development reported - Preclinical for Neuropathic pain in United Kingdom (PO)